Companhia Brasiliera De Distribuicao Stock To Go Ex-dividend Tomorrow (CBD)

NEW YORK ( TheStreet) -- The ex-dividend date for Companhia Brasiliera de Distribuicao (NYSE: CBD) is tomorrow, April 28, 2011. Owners of shares as of market close today will be eligible for a dividend of 0 cents per share. At a price of $43.98 as of 9:35 a.m. ET, the dividend yield is 0.6%.

The average volume for Companhia Brasiliera de Distribuicao has been 515,500 shares per day over the past 30 days. Companhia Brasiliera de Distribuicao has a market cap of $11.4 billion and is part of the services sector and retail industry. Shares are up 4.8% year to date as of the close of trading on Tuesday.

Companhia Brasileira de Distribuicao operates as a retailer of food, clothing, home appliances, and other products through its chain of hypermarkets, supermarkets, and specialized and department stores primarily in Brazil. The company has a P/E ratio of 48.5, above the average retail industry P/E ratio of 26 and above the S&P 500 P/E ratio of 16.7.
  • Practice your dividend trading strategies and win cash in our stock game.

TheStreet Ratings rates Companhia Brasiliera de Distribuicao as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, compelling growth in net income, attractive valuation levels and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full Companhia Brasiliera de Distribuicao Ratings Report.

See our dividend calendar or top-yielding stocks list.

null

More from Markets

Dow Tumbles as Trump Ratchets Up China Trade Fight

Dow Tumbles as Trump Ratchets Up China Trade Fight

Netflix Shares Hit All-Time High as Market Flounders

Netflix Shares Hit All-Time High as Market Flounders

Snap Shares Plunge After Cowen Cuts Price Target

Snap Shares Plunge After Cowen Cuts Price Target

FANG Stocks Get Swept Up in Broader Market Selloff

FANG Stocks Get Swept Up in Broader Market Selloff

Sarepta Shares Skyrocket on Early Results for DMD Gene Therapy

Sarepta Shares Skyrocket on Early Results for DMD Gene Therapy